Literature DB >> 7904208

Close linkage with the RET protooncogene and boundaries of deletion mutations in autosomal dominant Hirschsprung disease.

Y Luo1, I Ceccherini, B Pasini, I Matera, M P Bicocchi, V Barone, R Bocciardi, H Kääriäinen, D Weber, M Devoto.   

Abstract

Tight linkage with the RET proto-oncogene (Zmax = 3.41 at theta = 0.00), analysis of recombinants and detection of a familial microdeletion in a large pedigree restrict the mapping of the Hirschsprung (HSCR) gene previously localized on proximal 10q. The molecular characterization of the familial microdeletion and of 3 additional cytogenetically visible de novo deletions, isolated in somatic cell hybrids, identify a smallest region of overlap of 250 Kb. This contains the RET proto-oncogene where missense mutations causing multiple endocrine neoplasia type 2A (MEN 2A) phenotype were recently found. The pentagastrin test (which detects preclinical forms of MEN 2A or B) is negative in adult HSCR patients with deletions of the RET gene. This represents a good candidate for the search of mutations causing HSCR.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7904208     DOI: 10.1093/hmg/2.11.1803

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  17 in total

1.  Genetic background impacts developmental potential of enteric neural crest-derived progenitors in the Sox10Dom model of Hirschsprung disease.

Authors:  Lauren C Walters; V Ashley Cantrell; Kevin P Weller; Jack T Mosher; E Michelle Southard-Smith
Journal:  Hum Mol Genet       Date:  2010-08-25       Impact factor: 6.150

2.  Molecular heterogeneity of RET loss of function in Hirschsprung's disease.

Authors:  F Carlomagno; G De Vita; M T Berlingieri; V de Franciscis; R M Melillo; V Colantuoni; M H Kraus; P P Di Fiore; A Fusco; M Santoro
Journal:  EMBO J       Date:  1996-06-03       Impact factor: 11.598

Review 3.  [Molecular biology, basic research and diagnosis of Hirschsprung's disease].

Authors:  G Martucciello; O Luinetti; P Romano; U Magrini
Journal:  Pathologe       Date:  2007-03       Impact factor: 1.011

4.  Mutations in the extracellular domain cause RET loss of function by a dominant negative mechanism.

Authors:  M P Cosma; M Cardone; F Carlomagno; V Colantuoni
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

Review 5.  Multiple endocrine neoplasia syndromes, children, Hirschsprung's disease and RET.

Authors:  S W Moore; M G Zaahl
Journal:  Pediatr Surg Int       Date:  2008-03-26       Impact factor: 1.827

Review 6.  The RET proto-oncogene: a challenge to our understanding of disease pathogenesis.

Authors:  T Kusafuka; P Puri
Journal:  Pediatr Surg Int       Date:  1997       Impact factor: 1.827

7.  A newborn with ring chromosome 10, aganglionic megacolon, and renal hypoplasia.

Authors:  G Calabrese; P G Franchi; L Stuppia; R Mingarelli; C Rossi; L Ramenghi; M Marino; E Morizio; R Peila; A Antonucci
Journal:  J Med Genet       Date:  1994-10       Impact factor: 6.318

8.  A meta-analysis of clinical outcome in patients with total intestinal aganglionosis.

Authors:  Elke Ruttenstock; Prem Puri
Journal:  Pediatr Surg Int       Date:  2009-10       Impact factor: 1.827

9.  Expression of dishevelled gene in Hirschsprung's disease.

Authors:  Dong Chen; Jie Mi; Mei Wu; Weilin Wang; Hong Gao
Journal:  Int J Clin Exp Pathol       Date:  2013-08-15

Review 10.  Chromosomal and related Mendelian syndromes associated with Hirschsprung's disease.

Authors:  S W Moore
Journal:  Pediatr Surg Int       Date:  2012-09-23       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.